retatrutide clinical trials weight loss retatrutide VisualAbstract: reduces body by 17.5% in patients with obesity A New Obesity Drug Delivered

Hers is a telehealth platform, not a pharmacy

American Board of Psychiatry and Neurology (ABPN) This activity has been designed to satisfy the CME requirements of the American Board of Psychiatry and Neurologys Continuing Certification (CC) requirements

This includes eligibility screening, dose titration, a critical phase in tirzepatide therapy where doses advance from the 2.5 mg starting dose through escalating levels (5 mg, 7.5 mg, 10 mg, and 12.5 mg or 15 mg), and ongoing monitoring of metabolic and clinical outcomes

The announcement comes a day after Eli Lilly and Novo Nordisk shares moved in opposite directions following their latest earnings reports, as Novo Nordisk warned of sales could decline this year, while Eli Lilly said its sales are expected to keep growing